Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Eur Ann Allergy Clin Immunol ; 56(1): 17-25, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36927838

RESUMEN

Summary: Background. International guidelines suggested skin tests with Polyethylene-glycol (PEG) and polysorbate 80 (PS-80), to investigate a possible hypersensitivity to these excipients either to identify subjects at risk of developing allergic reactions to Covid-19 vaccines, or in patients with suspected IgE mediated hypersensitivity reactions (HR) to the Covid-19 vaccine. The main purpose of this study was to investigate the prevalence of PEG and PS sensitization in patients with a clinical history of HR to drugs containing PEG/PS and in patients with a suspected Covid-19 vaccine immediate HR. Methods. This was a multicenter retrospective study conducted by allergists belonging to 20 Italian medical centers. Skin testing was performed in 531 patients with either a clinical history of suspected hypersensitivity reaction (HR) to drugs containing PEG and/or PS-80 (group 1:362 patient) or a suspected HR to Covid-19 vaccines (group 2: 169 patient), as suggested by the AAIITO/SIAAIC guidelines for the "management of patients at risk of allergic reactions to Covid-19 vaccines" [1]. Results. 10/362 (0.02%) had positive skin test to one or both excipients in group 1, 12/169 (7.1%) in group 2 (p less than 0.01). In group 2 HRs to Covid-19 vaccines were immediate in 10/12 of cases and anaphylaxis occurred in 4/12 of patients. Conclusions. The positivity of skin test with PEG and or PS before vaccination is extremely rare and mostly replaceable by an accurate clinical history. Sensitization to PEG and PS has to be investigated in patients with a previous immediate HR to a Covid-19 vaccine, in particular in patients with anaphylaxis.


Asunto(s)
Anafilaxia , COVID-19 , Hipersensibilidad Inmediata , Humanos , Polisorbatos/efectos adversos , Polietilenglicoles/efectos adversos , Vacunas contra la COVID-19/efectos adversos , COVID-19/epidemiología , COVID-19/prevención & control , Excipientes/efectos adversos , Anafilaxia/diagnóstico , Anafilaxia/epidemiología , Estudios Retrospectivos , Programas de Inmunización , Pruebas Cutáneas , Italia/epidemiología
2.
J Biol Regul Homeost Agents ; 33(6): 1669-1670, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31833336

RESUMEN

In this editorial the authors highlight recent findings which could help design a personalized approach for cancer immunotherapy.


Asunto(s)
Microbioma Gastrointestinal , Inmunoterapia , Neoplasias/microbiología , Neoplasias/terapia , Humanos
3.
J Biol Regul Homeost Agents ; 33(5): 1321-1326, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31663301

RESUMEN

It is now well-known that interleukins (ILs) play a pivotal role in shaping innate immunity: inflammatory ILs are responsible for all innate aspects of immune response, from the very first vascular reactions to the chronic non-specific response to inflammation; while anti-inflammatory ILs are responsible for keeping adaptive immunity at bay. The interactions between ILs and adaptive immunity have been long considered secondary to the effects on the innate immune system, but in recent years it has appeared more clearly that IL direct interactions with adaptive immunity are extremely important both in physiologic and pathologic immune response. In the present review we analyze the role of inflammatory ILs (IL-1, IL-6, IL-33 and IL-37) on adaptive immunity and briefly discuss the possible therapeutic perspectives of IL-blockade in adaptive immunity disorders.


Asunto(s)
Inmunidad Adaptativa , Citocinas/inmunología , Humanos , Interleucina-1 , Interleucina-33 , Interleucina-6
4.
J Biol Regul Homeost Agents ; 33(2): 315-319, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30942065

RESUMEN

In recent years, gut microbiota (GM) has emerged as a key factor in shaping the pathogenesis of a vast array of immune-mediated diseases, as well as in the response to immune-based treatments such as anti PD-1 and anti-CTLA4 therapy or influenza vaccination. In addition, GM has a significant role in the immune system development and is fundamental in developing mucosal immunity. Recent data suggest that GM plays an important role in the immune system of immune deficient patients. GM status has a remarkable impact on the immune system and in immune deficient patients; this can lead to important consequences. Prebiotics are indeed a promising candidate in restoring GM homeostasis and improving immunity. Antibiotics are also capable of altering the microbial equilibrium.


Asunto(s)
Inmunodeficiencia Variable Común/inmunología , Inmunodeficiencia Variable Común/microbiología , Microbioma Gastrointestinal , Inmunidad Mucosa , Citocinas/inmunología , Humanos , Sistema Inmunológico
5.
Curr Med Chem ; 25(42): 6070-6081, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29773050

RESUMEN

BACKGROUND: Vaccines are very effective medical tools for disease prevention and life span increase. Controversies have raised concern about their safety, from autism to polio vaccine contamination with simian virus 40 (SV-40). Hysteria surrounding vaccine-associated risks has resulted in a declining number of vaccinations in developed countries. Outbreaks of vaccine-preventable diseases (e.g. measles) have occurred in Europe and North America, causing also some causalities. OBJECTIVES: In this review, data on safety and efficacy of vaccines are discussed, showing that the benefits of vaccines far outweigh the risks and that it is important to comply with vaccination protocols, to avoid spreading of severe, preventable diseases. METHODS: Those opposed to vaccinations suggest that scientific literature supporting vaccines is influenced by pharmaceutical companies. In this review, studies on influenza produced by independent scientists and those authored by those who received some kind of benefit from the industry are discussed separately. All the chosen papers were selected through a MEDLINE research. RESULTS: Vaccination rates are decreasing, even though they are effective public health tools. Influenza, for example, is responsible for 250,000-500,000 deaths each year, according to the WHO. Yet, campaigns to extend influenza vaccine to all elderly subjects report little success, because of the vaccine scare and because not all patients develop immunity following vaccination. CONCLUSIONS: This review proves that vaccine hysteria is detrimental because: 1) it causes an increased morbidity and mortality from preventable diseases; 2) it jeopardizes research for new vaccines; 3) patients are reluctant to accept any form of immune-therapy, commonly referred to as "vaccination".


Asunto(s)
Vacunación/psicología , Vacunas/efectos adversos , Trastorno del Espectro Autista/etiología , Países Desarrollados , Síndrome de Guillain-Barré/etiología , Humanos , Gripe Humana/inmunología , Gripe Humana/prevención & control , Gripe Humana/psicología , Medicina Preventiva , Timerosal/efectos adversos , Vacunación/estadística & datos numéricos , Vacunas/inmunología
6.
Clin Ter ; 166(2): e132-9, 2015.
Artículo en Italiano | MEDLINE | ID: mdl-25945447

RESUMEN

Even though necrotizing fasciitis is considered a rare disease, the spreading of the predisposing factors such as diabetes and chronic diseases, contribute to increase the incidence of this infection. Thus, how to diagnose and treat this clinical pathology, which represents an emerging need. This infection could be fatal for patients if not early diagnosed and treated and it represents a challenge both for the clinicians both for the surgeons. From this consideration was born the idea to write this review article in order to furnish to the readers a helpful tool in the management of this disease starting from its clinical and epidemiological features leading to the diagnosis, both clinical and radiological, and concluding with the treatment both medical both surgical .This article reviews literature on PubMed/MEDLINE with key words "necrotizing", "fasciitis" and "necrotizing fasciitis" from 1967 to 2014, considering all the aspects of the disease. The authors attempt to draw comparisons to their own experience managing this condition to give an Italian perspective to the condition.


Asunto(s)
Fascitis Necrotizante/diagnóstico , Fascitis Necrotizante/epidemiología , Fascitis Necrotizante/cirugía , Humanos , Incidencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA